SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective …
GA Van Hazel, V Heinemann, NK Sharma… - Journal of Clinical …, 2016 - ascopubs.org
Purpose SIRFLOX was a randomized, multicenter trial designed to assess the efficacy and
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
[PDF][PDF] SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus …
GA van Hazel, V Heinemann, NK Sharma… - …, 2016 - phdres.caregate.net
Purpose SIRFLOX was a randomized, multicenter trial designed to assess the efficacy and
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective …
GA Van Hazel, V Heinemann, NK Sharma… - Journal of Clinical …, 2016 - pure.psu.edu
Purpose: SIRFLOX was a randomized, multicenter trial designed to assess the efficacy and
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective …
GA van Hazel, V Heinemann… - Journal of clinical …, 2016 - repository.uantwerpen.be
Purpose SIRFLOX was a randomized, multicenter trial designed to assess the efficacy and
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus …
P Eliadis, R Isaacs, D Price… - Journal of Clinical …, 2016 - univ-rennes.hal.science
PURPOSE: SIRFLOX was a randomized, multicenter trial designed to assess the efficacy
and safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
and safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus …
GA van Hazel, V Heinemann, NK Sharma… - Journal of Clinical …, 2016 - europepmc.org
Purpose SIRFLOX was a randomized, multicenter trial designed to assess the efficacy and
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective …
G Van Hazel, V Heinemann… - Journal of …, 2016 - research-repository.uwa.edu.au
Abstract© 2016 by American Society of Clinical Oncology. Purpose: SIRFLOX was a
randomized, multicenter trial designed to assess the efficacy and safety of adding selective …
randomized, multicenter trial designed to assess the efficacy and safety of adding selective …
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus …
GA van Hazel, V Heinemann… - Journal of clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose SIRFLOX was a randomized, multicenter trial designed to assess the efficacy and
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
[PDF][PDF] SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus …
GA van Hazel, V Heinemann, NK Sharma… - J Clin …, 2016 - theranostics.sg
Purpose SIRFLOX was a randomized, multicenter trial designed to assess the efficacy and
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus …
GA van Hazel, V Heinemann, NK Sharma… - Journal of Clinical …, 2016 - hero.epa.gov
PURPOSE: SIRFLOX was a randomized, multicenter trial designed to assess the efficacy
and safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …
and safety of adding selective internal radiation therapy (SIRT) using yttrium-90 resin …